Clinical Trials Browser

Myelodysplastic Syndromes × Zoledronic Acid × Gynecologic × Clear all

NCT00321932 2017-03-09

Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant

Phase 2 Completed

61 enrolled 16 charts

GynecologicLymphoidMyeloidOther hematologic neoplasm

Leukemia, Lymphoma, Myelodysplastic Syndromes, Osteoporosis, Ovarian Neoplasms